Zivo Bioscience, Inc.

Zivo Bioscience, Inc. operates as a research and development company focused on the biotechnology and agtech sectors. The company centers its operations on two core segments: therapeutics and nutrition, utilizing proprietary algal and bacterial cultures. In the biotech therapeutic segment, it develops bioactive molecules and extracts to combat animal and human health conditions, including poultry coccidiosis, avian influenza, and bovine mastitis. In the agtech nutrition segment, the company produces dried green algae powder for human consumption as a whole food product or functional dietary ingredient. Zivo targets partnerships with established animal health companies for licensing and commercialization, while distributing its nutrition products through third-party marketing and direct-to-consumer platforms.

The company collaborates with a contract manufacturing partner that operates commercial algae cultivation ponds and production facilities in Peru. Distribution is primarily directed toward the North American green powder food market. The provided text does not mention the location of the company's corporate headquarters.

Summary of the business section of Zivo Bioscience's latest annual report, written by StockData.

“As of December 31, 2024 we had seven full-time employees, consisting of clinical development, product development, regulatory, manufacturing, quality, finance, and administration.”